StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
18
This year
2
Publishing Date
2024 - 02 - 21
1
2024 - 02 - 16
1
2023 - 08 - 21
1
2023 - 03 - 03
1
2023 - 01 - 16
1
2023 - 01 - 04
1
2022 - 12 - 06
1
2022 - 10 - 19
1
2022 - 09 - 26
1
2022 - 02 - 23
1
2022 - 02 - 07
1
2021 - 12 - 06
1
2021 - 11 - 02
1
2021 - 10 - 07
1
2021 - 10 - 06
1
2021 - 08 - 16
1
2021 - 06 - 18
1
2021 - 05 - 01
1
Sector
Health technology
18
Manufacturing
1
Producer manufacturing
1
Tags
America
67
Antibody
13
Application
12
Approval
21
Biosimilar
39
Breast
13
Cancer
106
Covid
17
Covid-19
12
Device
14
Diabetes
18
Diagnostics
19
Disease
76
Drug
115
Drug delivery
11
Earnings
21
Europe
17
Expansion
11
Expected
35
Eye
21
Fda
28
Financial
24
Financial results
13
Gene therapy
11
Global
229
Growing
47
Growth
262
Health
19
Immunotherapy
12
Kisqali
11
Leukemia
12
Liver
20
Market
599
N/a
1115
Novartis
133
Patent
13
People
20
Pharma
17
Pharmaceuticals
17
Pipeline
12
Positive
19
Potential
13
Reach
34
Report
195
Research
129
Respiratory
15
Results
52
Risk
11
Sales
11
Sclerosis
13
Set
16
Study
17
T-cell
12
Technology
14
Therapeutics
114
Therapy
89
Treatment
137
Trial
25
Vaccine
16
Year
12
Entities
Abbott laboratories
31
Adhera therapeutics, inc.
4
Akero therapeutics, inc.
3
Altimmune, inc.
3
Amgen inc.
3
Applied therapeutics, inc.
3
Astrazeneca plc
16
Baxter international inc.
6
Becton, dickinson and company
15
Better therapeutics inc
11
Bio-rad laboratories, inc.
3
Biomea fusion inc
27
Biora therapeutics inc
3
Biovie inc.
3
Boston scientific corporation
3
Clearside biomedical, inc.
3
Creative medical technology holdings, inc.
4
Crispr therapeutics ag
4
Danaher corporation
3
Dariohealth corp.
4
Dexcom, inc.
25
Eli lilly and company
57
Embecta corp.
5
Evotec se
7
Evotec se - adr
4
Genprex, inc.
6
Glaxosmithkline plc
7
Incyte corporation
6
Insulet corporation
20
Johnson & johnson
17
Lexicon pharmaceuticals, inc.
11
Mannkind corporation
12
Medicinova, inc.
4
Medtronic plc
26
Metacrine, inc.
4
Nemaura medical inc.
9
Nevro corp.
9
Novartis ag
18
Novo nordisk a/s
34
Ocuphire pharma inc.
4
Oramed pharmaceuticals inc.
9
Orange
7
Panbela therapeutics inc
4
Pfizer, inc.
4
Provention bio, inc.
15
Regenxbio inc.
4
Renalytix ai plc
6
Renalytix plc
5
Sab biotherapeutics inc
7
Sanofi
60
Senseonics holdings, inc.
13
Sernova corp.
14
Tandem diabetes care, inc.
34
Terumo corp
7
Trinity biotech plc
4
Unilever plc
5
Vertex pharmaceuticals incorporated
10
Vtv therapeutics inc.
11
Zealand pharma a/s
7
Zyversa therapeutics inc
4
Symbols
ABT
3
ALC
1
ALPMF
1
ALPMY
1
AMGN
2
AZN
8
AZNCF
7
BAX
2
BDX
1
BHC
1
BSX
1
GLAXF
3
GSK
4
IEX
1
IRIX
1
JNJ
5
KOD
1
LLY
1
NVO
2
NVS
18
NVSEF
15
PFE
2
REGN
1
RETA
1
SNY
9
SNYNF
8
STAA
2
TAK
1
Exchanges
Nasdaq
16
Nyse
18
Crawled Date
2024 - 02 - 21
1
2024 - 02 - 16
1
2023 - 08 - 21
1
2023 - 03 - 03
1
2023 - 01 - 16
1
2023 - 01 - 04
1
2022 - 12 - 06
1
2022 - 10 - 19
1
2022 - 09 - 26
1
2022 - 02 - 23
1
2022 - 02 - 07
1
2021 - 12 - 06
1
2021 - 11 - 02
1
2021 - 10 - 07
1
2021 - 10 - 06
1
2021 - 08 - 16
1
2021 - 06 - 18
1
2021 - 05 - 01
1
Crawled Time
02:00
1
03:00
1
04:00
2
07:00
1
10:00
2
11:00
1
12:00
2
12:20
1
13:00
1
13:15
1
16:00
3
23:00
2
Source
www.globenewswire.com
1
www.prnewswire.com
17
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Diabetes
entities :
Novartis ag
save search
Global Incretin Based Drugs Research Report 2023: Market to Reach $64.28 Billion by 2029 from $40 Billion in 2022, Driven by Increasing Prevalence of Diabetes
Published:
2024-02-21
(Crawled : 02:00)
- prnewswire.com
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
5.99%
|
O:
-0.88%
H:
1.75%
C:
-0.29%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-8.14%
|
O:
-0.65%
H:
0.62%
C:
0.5%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
-3.88%
|
O:
-2.33%
H:
1.55%
C:
1.06%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
5.4%
|
O:
-1.01%
H:
1.1%
C:
1.1%
report
reach
research
global
diabetes
market
Global Intraocular Lens Market Report 2024: Market to Grow from $4.23 Billion in 2023 to $6.11 Billion by 2030 - Rising Incidence of Myopia and Diabetes Boosts Demand
Published:
2024-02-16
(Crawled : 23:00)
- prnewswire.com
BHC
|
$8.69
1.05%
0.0%
2.9M
|
Health Technology
|
Email alert
Add to watchlist
ALC
|
$79.55
1.38%
-0.25%
1.1M
|
Health Technology
|
Email alert
Add to watchlist
STAA
|
$46.43
-0.73%
-0.73%
400K
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
Email alert
Add to watchlist
report
global
diabetes
market
Global Diabetes Drugs Market to Reach $106.65 Billion by 2028: Rising Prevalence of Diabetes Fuels Growth
Published:
2023-08-21
(Crawled : 16:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-13.9%
|
O:
-0.02%
H:
0.0%
C:
0.0%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
0.12%
|
O:
0.16%
H:
0.51%
C:
0.51%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-6.59%
|
O:
1.5%
H:
0.52%
C:
0.43%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-14.68%
|
O:
-2.16%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-12.82%
|
O:
1.17%
H:
0.0%
C:
0.0%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
0.13%
|
O:
0.76%
H:
0.23%
C:
-0.14%
reach
global
diabetes
growth
market
Type 2 diabetes market size to increase by USD 39.37 billion between 2022 and 2027; Growth driven by increasing prevalence of diabetes - Technavio
Published:
2023-03-03
(Crawled : 16:00)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
17.61%
|
O:
0.09%
H:
1.57%
C:
1.51%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
3.53%
|
O:
-1.0%
H:
0.73%
C:
-0.19%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
36.1%
|
O:
0.99%
H:
0.0%
C:
-0.1%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
10.86%
|
O:
-0.55%
H:
0.27%
C:
0.04%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
14.95%
|
O:
-0.38%
H:
0.65%
C:
0.61%
BAX
|
$39.47
-0.45%
0.0%
2.8M
|
Health Technology
|
-0.38%
|
O:
1.11%
H:
0.67%
C:
-0.3%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-2.79%
|
O:
-0.46%
H:
0.0%
C:
0.0%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
5.3%
|
O:
-0.61%
H:
0.8%
C:
0.77%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
14.57%
|
O:
0.11%
H:
0.38%
C:
-0.08%
diabetes
growth
market
Diabetic Macular Edema Treatment Global Market Report 2022: Prevalence of Diabetes Worldwide Bolsters Sector
Published:
2023-01-16
(Crawled : 12:00)
- prnewswire.com
IEX
|
$227.04
0.42%
0.0%
240K
|
Producer Manufacturing
|
Email alert
Add to watchlist
REGN
|
$896.27
0.26%
0.25%
500K
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
Email alert
Add to watchlist
IRIX
|
$2.95
-2.32%
-2.37%
50K
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
treatment
global
report
macular
diabetes
market
diabetic
Global Type 2 Diabetes Treatment Market Outlook Report 2022-2023 & 2027: Patent Cliff, Oral Antidiabetics, and Growing Focus on Accessibility and Affordability of Medicine Bolsters Growth
Published:
2023-01-04
(Crawled : 23:00)
- prnewswire.com
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
-1.33%
|
O:
-0.93%
H:
3.08%
C:
3.08%
NVO
|
News
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
-10.28%
|
O:
-0.89%
H:
1.18%
C:
0.52%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
2.74%
|
O:
-0.85%
H:
0.2%
C:
-0.29%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-17.89%
|
O:
-0.62%
H:
0.54%
C:
-0.12%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-5.99%
|
O:
-3.07%
H:
0.0%
C:
0.0%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
-1.37%
|
O:
-0.49%
H:
1.65%
C:
0.94%
treatment
patent
global
report
growing
diabetes
growth
market
Type 2 diabetes market 2023-2027: 5-year (2017-2021) historic industry size and analysis of 15 vendors and 7 countries - Technavio
Published:
2022-12-06
(Crawled : 04:00)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
17.78%
|
O:
2.04%
H:
8.0%
C:
7.71%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
4.33%
|
O:
0.74%
H:
8.46%
C:
8.46%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
24.55%
|
O:
-1.97%
H:
0.05%
C:
0.05%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
3.74%
|
O:
0.03%
H:
0.26%
C:
-0.27%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
13.05%
|
O:
-1.19%
H:
14.39%
C:
9.15%
BAX
|
$39.47
-0.45%
0.0%
2.8M
|
Health Technology
|
-23.06%
|
O:
-0.58%
H:
1.71%
C:
1.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
2.96%
|
O:
0.33%
H:
0.0%
C:
0.0%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
0.19%
|
O:
-0.48%
H:
1.59%
C:
0.69%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-5.61%
|
O:
0.33%
H:
0.56%
C:
-0.89%
diabetes
market
Diabetes Therapeutics Market Worth $91+ Billion, Globally, by 2028 at 6+% CAGR | The Insight Partners
Published:
2022-10-19
(Crawled : 11:00)
- prnewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
48.61%
|
O:
-1.98%
H:
0.0%
C:
0.0%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
4.17%
|
O:
-1.18%
H:
0.56%
C:
-1.11%
NVO
|
News
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
15.0%
|
O:
-0.38%
H:
0.04%
C:
-1.58%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
21.77%
|
O:
-0.52%
H:
0.06%
C:
-0.75%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-10.37%
|
O:
0.46%
H:
0.0%
C:
0.0%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
27.2%
|
O:
0.96%
H:
0.22%
C:
-0.76%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
14.15%
|
O:
-1.37%
H:
0.0%
C:
0.0%
therapeutics
diabetes
market
Alpha Glucosidase Inhibitors Market to record USD 567.96 Mn incremental growth -- Driven by increase in awareness of diabetes and growing initiatives
Published:
2022-09-26
(Crawled : 07:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
26.36%
|
O:
5.77%
H:
0.0%
C:
-2.27%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
25.7%
|
O:
-1.15%
H:
0.0%
C:
-2.43%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
24.14%
|
O:
-2.04%
H:
0.82%
C:
0.2%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
20.64%
|
O:
-2.29%
H:
0.35%
C:
-0.67%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
25.6%
|
O:
-1.52%
H:
0.48%
C:
-1.36%
growing
diabetes
growth
market
Intraocular Lens Market to Expand Owing to Rise in Diabetic Population, States TMR Study
Published:
2022-02-23
(Crawled : 03:00)
- prnewswire.com
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
9.94%
|
O:
1.82%
H:
0.07%
C:
-1.0%
STAA
|
$46.43
-0.73%
-0.73%
400K
|
Health Technology
|
-29.61%
|
O:
0.52%
H:
0.29%
C:
-4.91%
ocular
state
diabetic
diabetes
Diabetic Neuropathy Drugs Market: Segmentation by product (calcium channel alpha-2-delta ligand, SNRIs and TCAs, and others) and geography (North America, Europe, Asia, and ROW)--Forecast till 2025|Technavio
Published:
2022-02-07
(Crawled : 10:00)
- prnewswire.com
ALPMF
|
$9.17
43.47%
16K
|
Health Technology
|
-41.86%
|
O:
7.04%
H:
0.0%
C:
-5.13%
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
23.22%
|
O:
2.69%
H:
0.5%
C:
-1.76%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
9.94%
|
O:
1.0%
H:
0.59%
C:
0.59%
ALPMY
|
$9.47
-1.11%
520K
|
Manufacturing
|
-45.12%
|
O:
1.1%
H:
0.69%
C:
0.0%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
9.45%
|
O:
1.03%
H:
0.0%
C:
0.0%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
21.82%
|
O:
-0.14%
H:
1.01%
C:
0.87%
america
europe
drug
diabetic
diabetes
BD Selects "embecta" as Name of New Company for Planned Spinoff of Diabetes Care Business; Announces Remainder of Leadership Team
Published:
2021-12-06
(Crawled : 12:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-3.51%
|
O:
-4.23%
H:
0.11%
C:
0.11%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
18.68%
|
O:
2.02%
H:
0.04%
C:
-0.89%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
16.88%
|
O:
-0.57%
H:
0.0%
C:
0.0%
BSX
|
$67.33
-0.13%
-0.31%
7M
|
Health Technology
|
69.09%
|
O:
0.04%
H:
0.0%
C:
0.0%
BDX
|
$234.12
0.42%
0.0%
1.3M
|
Health Technology
|
-4.02%
|
O:
0.68%
H:
0.0%
C:
0.0%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-17.0%
|
O:
1.15%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-2.44%
|
O:
0.02%
H:
0.0%
C:
0.0%
ema
diabetes
Diabetes Associated Ophthalmic Treatment Market Size $44.7 Billion By 2028: Grand View Research, Inc.
Published:
2021-11-02
(Crawled : 10:00)
- prnewswire.com
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-41.08%
|
O:
2.06%
H:
0.0%
C:
0.0%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
12.55%
|
O:
0.3%
H:
0.15%
C:
-0.4%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-9.41%
|
O:
0.26%
H:
2.0%
C:
1.15%
diabetes
treatment
research
Diabetic Macular Edema Market size worth $ 4.87 Billion, Globally, by 2028 at 2.86% CAGR: Verified Market Research®
Published:
2021-10-07
(Crawled : 13:15)
- prnewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
15.09%
|
O:
2.72%
H:
0.1%
C:
0.1%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
15.37%
|
O:
0.62%
H:
1.0%
C:
0.22%
KOD
|
$3.36
-3.17%
-3.27%
600K
|
Health Technology
|
-96.68%
|
O:
0.34%
H:
4.38%
C:
2.23%
research
macular
diabetic
diabetes
Global Diabetic Nephropathy Treatment Market to Reach $3.5 Billion by 2026
Published:
2021-10-06
(Crawled : 16:00)
- prnewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
14.19%
|
O:
0.18%
H:
0.0%
C:
-0.96%
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-38.56%
|
O:
-0.61%
H:
0.33%
C:
-0.1%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
15.31%
|
O:
-0.55%
H:
0.71%
C:
0.5%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-7.42%
|
O:
-0.11%
H:
0.7%
C:
0.64%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-4.18%
|
O:
-0.87%
H:
0.8%
C:
0.63%
RETA
|
$172.36
0.02%
0.03%
0
|
Health Technology
|
74.52%
|
O:
-0.77%
H:
1.42%
C:
-1.5%
treatment
nephropathy
diabetic
diabetes
Global Diabetic Retinopathy Market (2021 to 2026) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts
Published:
2021-08-16
(Crawled : 13:00)
- prnewswire.com
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
1.0%
|
O:
0.34%
H:
0.99%
C:
0.77%
growth
diabetic
diabetes
Non-insulin Diabetes Therapeutics Market|$ 22.95 billion growth expected during 2021-2025|17000+ Technavio Research Reports
Published:
2021-06-18
(Crawled : 04:00)
- prnewswire.com
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
0.22%
|
O:
-0.78%
H:
0.17%
C:
-0.43%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
-2.02%
|
O:
-1.48%
H:
0.4%
C:
-0.33%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-3.9%
|
O:
-1.46%
H:
1.23%
C:
0.3%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-13.04%
|
O:
-1.9%
H:
1.38%
C:
1.21%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
17.48%
|
O:
-0.89%
H:
1.33%
C:
0.93%
diabetes
insulin
growth
research
Novartis Phase III Beovu® data show potential for fluid resolution in more diabetic macular edema patients with fewer injections versus aflibercept
Published:
2021-05-01
(Crawled : 12:20)
- globenewswire.com
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
Email alert
Add to watchlist
potential
injection
macular
diabetic
diabetes
Gainers vs Losers
67%
33%
Top 10 Gainers
GBR
|
$1.42
31.48%
11.27%
990K
|
Energy Minerals
KUKE
|
$2.88
2.49%
7.64%
360K
|
CXM
4
|
$11.34
-0.44%
4.27%
1.7M
|
Information
PVL
4
|
$1.47
-0.68%
4.08%
77K
|
Energy Minerals
RNR
4
|
$224.74
0.85%
3.52%
310K
|
Finance
BSBR
|
$5.25
2.54%
0.38%
430K
|
Finance
DV
|
News
|
$29.43
-2.36%
0.24%
1.9M
|
Information
JOE
4
|
$54.88
1.22%
0.22%
210K
|
Finance
JEF
4
|
$42.17
1.57%
0.07%
1.8M
|
Finance
MUSA
4
|
$417.23
1.06%
0.01%
170K
|
Retail Trade
Your saved searches
Save your searches and get alerts when important news are released.